Creating, facilitating, and promoting sustainable Health Technology Assessment (HTA) cooperation in Europe
PTRCR15 – Remdesivir for the treatment of COVID-19. PICO and Evidence gaps – Final Rapid Collaborative Review now available
This is the first pharmaceutical Rapid Collaborative Review (PTRCR15) for – Remdesivir for
Patient group input requested for a new Joint Assessment on a medicinal product for acute myeloid leukaemia (AML).
EUnetHTA deems patient involvement very important in the production of Joint Assessment
